- Home
- EHTH vs ASRT Comparison
EHTH vs ASRT Comparison
Compare EHTH & ASRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EHTH
- ASRT
- Stock Information
- Founded
- EHTH 1997
- ASRT 1995
- Country
- EHTH United States
- ASRT United States
- Employees
- EHTH N/A
- ASRT N/A
- Industry
- EHTH Specialty Insurers
- ASRT Biotechnology: Pharmaceutical Preparations
- Sector
- EHTH Finance
- ASRT Health Care
- Exchange
- EHTH Nasdaq
- ASRT Nasdaq
- Market Cap
- EHTH 130.5M
- ASRT 123.9M
- IPO Year
- EHTH 2006
- ASRT 1997
- Fundamental
- Price
- EHTH $4.42
- ASRT $1.13
- Analyst Decision
- EHTH Hold
- ASRT Strong Buy
- Analyst Count
- EHTH 3
- ASRT 5
- Target Price
- EHTH $6.67
- ASRT $3.35
- AVG Volume (30 Days)
- EHTH 116.9K
- ASRT 438.4K
- Earning Date
- EHTH 11-06-2024
- ASRT 11-06-2024
- Dividend Yield
- EHTH N/A
- ASRT N/A
- EPS Growth
- EHTH N/A
- ASRT N/A
- EPS
- EHTH N/A
- ASRT N/A
- Revenue
- EHTH $471,200,000.00
- ASRT $132,186,000.00
- Revenue This Year
- EHTH $8.91
- ASRT N/A
- Revenue Next Year
- EHTH $5.83
- ASRT $4.68
- P/E Ratio
- EHTH N/A
- ASRT N/A
- Revenue Growth
- EHTH 20.76
- ASRT N/A
- 52 Week Low
- EHTH $3.58
- ASRT $0.73
- 52 Week High
- EHTH $9.45
- ASRT $2.60
- Technical
- Relative Strength Index (RSI)
- EHTH 62.07
- ASRT 42.13
- Support Level
- EHTH $4.04
- ASRT $1.15
- Resistance Level
- EHTH $4.51
- ASRT $1.25
- Average True Range (ATR)
- EHTH 0.17
- ASRT 0.06
- MACD
- EHTH 0.06
- ASRT -0.01
- Stochastic Oscillator
- EHTH 86.96
- ASRT 14.29
About EHTH eHealth Inc.
eHealth Inc is a company involved in private health insurance marketplace with a technology and service platform that provides consumer engagement, education and health insurance enrollment solutions. The company operates its business in two segments: Medicare and Employer and Individual. It derives maximum revenue from Medicare Segment. All of the company's revenue is from the United States. It also has a presence in China.
About ASRT Assertio Holdings Inc.
Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults of age or older; and Zipsor, liquid-filled capsules for relief of mild to moderate pain.